FDA Import Refusal E46-7006796-3/1/1 — Malladi Drugs & Pharmaceuticals Ltd
The FDA refused shipment E46-7006796-3/1/1 from Malladi Drugs & Pharmaceuticals Ltd (India) on March 15, 2016. The refused product falls under Drugs and Biologics — PSEUDOEPHEDRINE HCL (ADRENERGIC). Cited charge: 16 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- March 15, 2016
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 60CQS10 PSEUDOEPHEDRINE HCL (ADRENERGIC)
- Charges
- 16